# Mesenchymal Stem Cell Therapy for Type 1 Diabetes Mellitus Patients

> **NCT03484741** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Van Hanh General Hospital** · enrollment: 15 (estimated)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **BIOLOGICAL:** MSC and PRP

## Key facts

- **NCT ID:** NCT03484741
- **Lead sponsor:** Van Hanh General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-04-01
- **Primary completion:** 2018-11
- **Final completion:** 2018-11
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2018-04-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03484741

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03484741, "Mesenchymal Stem Cell Therapy for Type 1 Diabetes Mellitus Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03484741. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*